KR830007643A - 벤조헤테로사이클 화합물의 제조방법 - Google Patents

벤조헤테로사이클 화합물의 제조방법 Download PDF

Info

Publication number
KR830007643A
KR830007643A KR1019810004344A KR810004344A KR830007643A KR 830007643 A KR830007643 A KR 830007643A KR 1019810004344 A KR1019810004344 A KR 1019810004344A KR 810004344 A KR810004344 A KR 810004344A KR 830007643 A KR830007643 A KR 830007643A
Authority
KR
South Korea
Prior art keywords
group
lower alkyl
substituted
compound
formula
Prior art date
Application number
KR1019810004344A
Other languages
English (en)
Other versions
KR880001625B1 (ko
Inventor
히로시 이시가와
데쯔유끼 우노
마사노부 가노
가즈뮤끼 나까가와
Original Assignee
오쯔까 아끼히꼬
오쯔까 세이야꾸 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55158652A external-priority patent/JPS5781486A/ja
Priority claimed from JP56063170A external-priority patent/JPS57176987A/ja
Application filed by 오쯔까 아끼히꼬, 오쯔까 세이야꾸 가부시끼 가이샤 filed Critical 오쯔까 아끼히꼬
Publication of KR830007643A publication Critical patent/KR830007643A/ko
Application granted granted Critical
Publication of KR880001625B1 publication Critical patent/KR880001625B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

벤조헤테로사이클 화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 다음 일반식(Ⅱ)의 화합물을 다음 일반식(Ⅲ)의 화합물과 반응시킴을 특징으로 하는 다음 일반식(Ⅰ)의 화합물 또는이의 약학적으로 무독한 염의 제조방법.
    상기 일반식에서
    R1는 수소원자 또는 저급알킬그룹이고
    R2는 수소원자 또는 할로겐원자이고
    R3는 하이드록시메틸그룹으로 치환될 수 있는 1-피롤리디닐그룸, 1, 2, 5, 6-테트라하이드로-1-피리딜그룹, 옥소그룹 또는 저급할로알킬그룹으로 치환된 1-피페라지닐그룹 또는 다음 일반식의 그룹이고
    (여기에서 R4는 수소원자, 저급알킬그룹, 저급알콕그룹, 하이드록시그룹, 페닐-저급알킬그룹, 저급알카노일옥시그룹, 저급알킬그룹 또는 저급알카노일그룹으로 치환될 수 있는 아미노그룹, 옥소그룹 또는 카바모일그룹이고,
    Z는 산소원자, 황원자 또는 메틸그룹이고,
    m은 1 또는 2이다).
    n은 1 또는 2의 정수이고,
    단 n이 2인 경우,
    R3는 저급할로알킬그룹으로 치환된 1-피페라지닐그룹이 될 수 없으며,
    X1은 할로겐원자, 저급알칸설포닐옥시그룹 또는 아릴설포닐옥시그룹이다.
  2. 다음 일반식 (Ⅴ)의 화합물을 다음 일반식(Ⅵ)의 화합물 또는 다음 일반식Ⅶ)의 화합물과 반응시킨다음 생성된 화합물을 폐환시키고 임의로 가수분해함을 특징으로 하는 다음 일반식(Ⅰ)의 화합물 또는 이의 약학적으로 무독한 염의 제조방법.
    상기 일반식에서
    R1은 수소원자 또는 저급알킬그룹이고
    R2는 수소원자 또는 할로겐원자이고
    R3는 하이드록시메틸그룹으로 치환될 수 있는 1-피롤리디닐그룹, 1,2,5,6-테트라하이드로-1-피리딜 그룹, 옥소그룹 또는 저급할로알킬그룹으로 치환된 1-피페라지닐그룹 또는 다음 일반식의 그룹이고
    (여기에 R4는 수소원자, 저급알킬그룹, 저급알콕시그룹, 하이드록시 그룹, 페닐-저급알킬그룹, 저급알카노일옥시그룹, 저급알킬그룹 또는 저급 알킬노일그룹으로 치환될 수 있는 아미노그룹, 옥소그룹 또는 카바모일 그룹이고, Z는 산소원자, 황원자 또는 메틸렌그룹이고 m은 1 또는 2이다).
    n은 1 또는 2의 정수이고
    단 n이 2인 경우,
    R3는 저급할로알킬그룹으로 치환된 1-피페라지닐그룹이 될 수 없으며,
    R6, R7및 R8은 각기 저급알킬그룹이고
    R9및 R10은 각기 저급알킬그룹이다.
  3. 다음 일반식(Ⅰb)의 화합물을 가수분해시킴을 특징으로 하는 다음 일반식(Ⅰ)화합물 또는 이의 약학적으로 무독한 염의 제조방법.
    상기 일반식에서
    R1은 수소원자 또는 저급알킬그룹이고
    R2는 수소원자 또는 할로겐원자이고
    R3는 하이드록시메틸그룹으로 치환될 수 있는 1-피롤리디닐그룹, 1,2,5,6-테트라하이드로-1-피리딜그룹, 옥소그룹 또는 저급할로알킬그룹으로 치환된 1-피페라지닐그룹 또는 다음 일반식의 그룹이고,
    (여기에서 R4는 수소원자, 저급알킬그룹, 저급알콕시그룹, 하이드록시 그룹, 페닐-저급알킬그룹, 저급알카노일옥시그룹, 저급알킬그룹 또는 저급 알킬노일그룹으로 치환될 수 있는 아미노그룹, 옥소그룹 또는 카바모일 그룹이고, Z는 산소원자, 황원자 또는 메틸렌그룹이고 m은 1 또는 2이다).
    n은 1 또는 2의 정수이고
    단 n이 2인 경우,
    R3는 저급할로알킬그룹으로 치환된 1-피페라지닐그룹이 될 수 없으며
    R11및 R12는 각기 수소원자 또는 저급알킬그룹이고
    Y는 함유된 3급 질소원자를 통해 결합되어 있는 방향족 헤테로사이클환 또는 트리알킬아민그룹이고
    Z는 음이온성 이온이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810004344A 1980-11-10 1981-11-10 벤조헤테로사이클 화합물의 제조방법 KR880001625B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP158652 1980-11-10
JP55158652A JPS5781486A (en) 1980-11-10 1980-11-10 Benzo(ij)quinolidine-2-carboxylic acid derivative
JP63170 1981-04-24
JP56063170A JPS57176987A (en) 1981-04-24 1981-04-24 Pyrrolo(3,2,1-ij)quinoline-5-carboxylic acid derivative

Publications (2)

Publication Number Publication Date
KR830007643A true KR830007643A (ko) 1983-11-04
KR880001625B1 KR880001625B1 (ko) 1988-09-02

Family

ID=26404260

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810004344A KR880001625B1 (ko) 1980-11-10 1981-11-10 벤조헤테로사이클 화합물의 제조방법

Country Status (19)

Country Link
US (2) US4399134A (ko)
KR (1) KR880001625B1 (ko)
AT (2) AT395150B (ko)
AU (1) AU546358B2 (ko)
CA (1) CA1179341A (ko)
CH (1) CH648845A5 (ko)
DE (2) DE10075035I2 (ko)
DK (1) DK160940C (ko)
ES (2) ES507493A0 (ko)
FI (1) FI71141C (ko)
FR (1) FR2493849A1 (ko)
GB (1) GB2086905B (ko)
IT (1) IT1171646B (ko)
NL (1) NL193457C (ko)
NO (1) NO156828C (ko)
PH (1) PH16685A (ko)
PT (1) PT73957B (ko)
SE (1) SE448542B (ko)
SU (2) SU1366055A3 (ko)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
US4380543A (en) * 1981-11-06 1983-04-19 Riker Laboratories, Inc. Antimicrobial 8-cyano-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acids
PH22140A (en) * 1982-06-29 1988-06-01 Daiichi Seiyaku Co Tricyclic compounds
US4443447A (en) * 1982-10-25 1984-04-17 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agents
JPS5978189A (ja) * 1982-10-26 1984-05-04 Otsuka Pharmaceut Co Ltd ピロロ〔3,2,1−ij〕キノリン−5−カルボン酸誘導体
US4472406A (en) * 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-8-(imidazol-1-yl)-5-methyl-1-oxo-1H,5H-benzo [ij]quinolizine-2-carboxylic acids and derivatives
JPS59137482A (ja) * 1983-01-26 1984-08-07 Otsuka Pharmaceut Co Ltd ピロロ〔3,2,1,−ij〕キノリン−5−カルボン酸誘導体
JPS59155381A (ja) * 1983-02-22 1984-09-04 Kyorin Pharmaceut Co Ltd ベンゾキノリジンカルボン酸誘導体及びその製造法
US4473568A (en) * 1983-03-01 1984-09-25 Warner Lambert Company Antibacterial thiazolidine or thiomorpholine substituted quinolines
US4472407A (en) * 1983-03-17 1984-09-18 Riker Laboratories, Inc. Antimicrobial 8-alkoxy-6,7-dihydro-5-methyl-9-fluoro-1-oxo-1H,5H-benzo[ij]qu
US4562195A (en) * 1984-02-02 1985-12-31 Warner-Lambert Company Reversing amnesia with saturated tricyclic nitrogen-containing diones
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
US4550103A (en) * 1984-07-20 1985-10-29 Warner-Lambert Company Antibacterial 1-oxo-benzoquinolizine-2-carboxylic acids
AU585981B2 (en) * 1985-05-24 1989-06-29 Tokyo Tanabe Company Limited Benzo (IJ) quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and processes for preparing the same
US5210193A (en) * 1986-01-17 1993-05-11 American Cyanamid Company Piperazine derivatives
US4940710A (en) * 1986-01-17 1990-07-10 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US4948894A (en) * 1989-02-21 1990-08-14 American Cyanamid Company 8-fluoro and 7, 8, 10-trifluoro-9-(substituted)-6-oxo-6H-benzo-(C)quinolizine-5-carboxylic acids
KR900014383A (ko) * 1989-03-29 1990-10-23 원본미기재 피롤로퀴놀린 유도체, 이의 제조방법 및 이를 사용한 항균제
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
ATE186642T1 (de) * 1993-03-10 1999-12-15 Otsuka Pharma Co Ltd Interleukin-1 inhibitor
EP0908181B8 (en) * 1996-05-20 2009-04-15 Otsuka Pharmaceutical Co., Ltd. Remedy for rosacea
DE19718065A1 (de) * 1997-04-29 1998-11-05 Henkel Kgaa Reinigungsmittel für nachvernetzende Polyurethan-Hotmelts
US6750224B1 (en) 1999-05-07 2004-06-15 Wockhardt Limited Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
EP1175217B8 (en) * 1999-05-07 2009-03-18 Wockhardt Limited (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents
US6514986B2 (en) 2000-11-22 2003-02-04 Wockhardt Limited Chiral fluoroquinolone arginine salt forms
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
AU7866701A (en) * 2000-05-08 2001-11-20 Shiv Kumar Agarwal Antibacterial chiral 8-(substituted piperidino)-benzo (i, j) quinolizines, processes, compositions and methods of treatment
WO2001085095A2 (en) * 2000-05-08 2001-11-15 Wockhardt Limited Chiral fluoroquinolizinone arginine salt forms
US6608078B2 (en) * 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
US6964966B2 (en) * 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
EP1453824A1 (en) * 2001-12-13 2004-09-08 Wockhardt Limited New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6664267B1 (en) * 2002-05-28 2003-12-16 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
EP1918289A3 (en) 2002-05-28 2009-08-19 Wockhardt Limited Crystalline nadifloxacin arginine salt form
WO2004058262A1 (en) * 2002-12-31 2004-07-15 Wockhardt Limited Benzoquinolizine-2-carboxylic acid-containing compositions
AU2003303367A1 (en) * 2002-12-31 2004-07-22 Noel J. De Souza Compositions of benzoquinolizine carboxylic acid antibiotic drugs
WO2005023805A1 (en) 2003-09-04 2005-03-17 Wockhardt Limited Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
DK1954697T3 (da) * 2005-10-21 2010-06-14 Glaxo Group Ltd Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler
CA2834548C (en) 2011-04-28 2021-06-01 The Broad Institute, Inc. Inhibitors of histone deacetylase
EP2877444B1 (en) 2012-07-27 2020-09-02 The Broad Institute, Inc. Inhibitors of histone deacetylase
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
SI3057964T1 (sl) 2013-10-14 2020-03-31 Eisai R&D Management Co., Ltd. Selektivno substituirane spojine kinolina
JP6483666B2 (ja) 2013-10-14 2019-03-13 エーザイ・アール・アンド・ディー・マネジメント株式会社 選択的に置換されたキノリン化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793524A (fr) * 1971-12-30 1973-06-29 Riker Laboratories Inc Acides benzoquinolizine-carboxyliques et leurs derives
US4001243A (en) * 1972-11-02 1977-01-04 Riker Laboratories, Inc. Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof
US3917609A (en) * 1973-06-27 1975-11-04 Minnesota Mining & Mfg Pyrroloquinoline carboxylic acids and derivatives
DE2953974C2 (ko) * 1978-04-12 1992-06-25 Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
US4416884A (en) * 1978-04-12 1983-11-22 Otsuka Pharmaceutical Co., Ltd. Piperazinylbenzoheterocyclic compounds
JPS6019910B2 (ja) * 1979-10-11 1985-05-18 大塚製薬株式会社 ベンゾ〔ij〕キノリジン−2−カルボン酸誘導体及びその製造法
JPS5540616A (en) * 1978-09-14 1980-03-22 Otsuka Pharmaceut Co Ltd Preparation of benzo-hetero-compound
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
JPS55149284A (en) * 1980-05-02 1980-11-20 Otsuka Pharmaceut Co Ltd Piperazinylbenzo heterocyclic derivative
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
AT380250B (de) * 1980-12-18 1986-04-25 Otsuka Pharma Co Ltd Verfahren zur herstellung benzoheterocyclischer verbindungen

Also Published As

Publication number Publication date
FR2493849A1 (fr) 1982-05-14
FR2493849B1 (ko) 1984-12-28
PH16685A (en) 1983-12-13
DE10075035I1 (de) 2001-02-22
GB2086905B (en) 1984-12-05
ATA288789A (de) 1991-03-15
PT73957A (en) 1981-12-01
NL8105075A (nl) 1982-06-01
IT8149656A0 (it) 1981-11-09
GB2086905A (en) 1982-05-19
DE3144455A1 (de) 1982-06-24
DE3144455C2 (ko) 1990-10-04
US4399134A (en) 1983-08-16
DK160940B (da) 1991-05-06
DE10075035I2 (de) 2002-03-28
NL193457C (nl) 1999-11-02
ES8301981A1 (es) 1983-02-01
CA1179341A (en) 1984-12-11
AT395150B (de) 1992-09-25
NO156828C (no) 1987-12-02
SE448542B (sv) 1987-03-02
AT393383B (de) 1991-10-10
FI71141C (fi) 1986-11-24
SE8106642L (sv) 1982-06-14
ES516523A0 (es) 1983-12-01
US4552879A (en) 1985-11-12
PT73957B (en) 1983-04-18
IT1171646B (it) 1987-06-10
SU1277896A3 (ru) 1986-12-15
AU546358B2 (en) 1985-08-29
ES8401035A1 (es) 1983-12-01
DK495281A (da) 1982-05-11
NO813726L (no) 1982-05-11
FI71141B (fi) 1986-08-14
NL193457B (nl) 1999-07-01
SU1366055A3 (ru) 1988-01-07
AU7733581A (en) 1982-08-05
CH648845A5 (de) 1985-04-15
DK160940C (da) 1991-10-21
ATA474881A (de) 1992-02-15
KR880001625B1 (ko) 1988-09-02
NO156828B (no) 1987-08-24
ES507493A0 (es) 1983-02-01
FI813526L (fi) 1982-05-11

Similar Documents

Publication Publication Date Title
KR830007643A (ko) 벤조헤테로사이클 화합물의 제조방법
KR840004441A (ko) 포스포리피드 유도체의 제조방법
KR840000540A (ko) N-옥사사이클릴-알킬피페리딘 유도체의 제조방법
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
KR860000243A (ko) 아민유도체의 제조방법
KR840005464A (ko) 포스포리피드 유도체의 제조방법
KR850006187A (ko) 신규 히달토인(Hydantoin) 유도체의 제조방법
KR860001064A (ko) β-락탐 화합물의 제조방법
KR860003234A (ko) N-치환된 트리아졸 유도체의 제조방법
KR850002460A (ko) 카르바메이트 화합물의 제조방법
KR870008830A (ko) 질산염 유도체의 제조 방법
KR860001097A (ko) 4-아미노-2-페닐퀴놀린의 제조방법
KR860001795A (ko) 트리아진 유도체의 제조방법
KR850004470A (ko) 유기 화합물의 제조방법
KR840006226A (ko) 티아트리아진 유도체의 제조방법
KR830006176A (ko) 치환된 펜옥시-아미노프로판올 유도체의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR840003633A (ko) 피리미돈 화합물의 제조방법
KR840005441A (ko) 헥사히드로디옥소피리미딘류의 제조방법
KR870002118A (ko) 벤질아민 유도체 및 그 제조방법
KR850007247A (ko) 바이페닐릴설포닐 우레아의 제조방법
KR860002451A (ko) 아미드 화합물의 제조방법
KR830007509A (ko) 아미노산 유도체의 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법